Pathological Features of High Proliferative Activity Neuroendocrine Tumor

#1595

Introduction: High Proliferative Activity Neuroendocrine Tumor (NET G3) is difficult to be distinguished from neuroendocrine carcinoma. However, there are differences in clinical treatment and prognosis between the two. So it is crucial to make an accurate pathological diagnosis.

Aim(s): The purpose of this study is to investigate the clinical pathological features of NET G3.

Materials and methods: The wax block of 10 NET G3 patients who were diagnosed between January 1st, 2010 to October 31th, 2016 in Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College were collected and stained.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Geng H, Shi S,

Keywords: high proliferative activity, neuroendocrine tumor, pathological feature,

To read the full abstract, please log into your ENETS Member account.